<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01661387</url>
  </required_header>
  <id_info>
    <org_study_id>Protocol 0918-400</org_study_id>
    <nct_id>NCT01661387</nct_id>
  </id_info>
  <brief_title>A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)</brief_title>
  <official_title>A European, Multi-Centre, Multi-Country, Post-Authorisation, Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shire</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shire</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      As a post-approval requirement of the European Medicines Agency, this European patient post
      authorization safety study is an observational study being conducted to monitor the safety of
      long-term treatment with Plenadren and other glucocorticoid replacement therapies in routine
      clinical practice in patients with chronic adrenal insufficiency (primary or secondary).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of intercurrent illness</measure>
    <time_frame>5 years</time_frame>
    <description>Monitor the safety of long-term treatment with PLENADREN and other glucocorticoid replacement therapies in patients with chronic AI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of adrenal crisis</measure>
    <time_frame>5 years</time_frame>
    <description>Monitor the safety of long-term treatment with PLENADREN and other glucocorticoid replacement therapies in patients with chronic AI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of serious adverse events</measure>
    <time_frame>5 years</time_frame>
    <description>Monitor the safety of long-term treatment with PLENADREN and other glucocorticoid replacement therapies in patients with chronic AI</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Chronic Adrenal Insufficiency</condition>
  <arm_group>
    <arm_group_label>Plenadren</arm_group_label>
    <description>Modified release hydrocortisone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other Glucocorticoid Replacement Therapy</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic adrenal insufficiency (primary or secondary) who are receiving
        Plenadren or other glucocorticoid replacement therapies at endocrinology centres in certain
        European countries as part of their routine clinical care. Approximately 20 sites are
        planned for enrollment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of chronic adrenal insufficiency

          -  Written informed consent/assent in compliance with applicable country-specific and
             local regulations

        Exclusion Criteria:

          -  Participation in an interventional clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shire Physician</last_name>
    <role>Study Director</role>
    <affiliation>Shire</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shire Contact</last_name>
    <email>protocol0918400@shire.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shire Transparency</last_name>
    <email>clinicaltransparency@shire.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathrin Zopf</last_name>
      <phone>0049 30450 51 4019</phone>
      <email>Kathrin.Zopf@charite.de</email>
    </contact>
    <investigator>
      <last_name>Tina Kienitz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endokrinologiepraxis am Stuttgarter Platz</name>
      <address>
        <city>Berlin</city>
        <zip>10627</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathrin Zopf</last_name>
      <phone>0049 302132004</phone>
      <email>praxis@endokrinologie-charlottenburg.de</email>
    </contact>
    <investigator>
      <last_name>Marcus Quinkler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Friedrich Alexander Universitat Erlangen Nurnberg</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monika Lindenberg</last_name>
      <phone>0049 9131853-5223</phone>
      <email>monika.lindenberg@uk-erlangen.de</email>
    </contact>
    <investigator>
      <last_name>Flavius Zoicas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Sandler</last_name>
      <phone>0049 069 6301 7818</phone>
      <email>maria.sandler@kgu.de</email>
    </contact>
    <investigator>
      <last_name>Klaus Badenhoop</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LMU Klinikum der Universität München</name>
      <address>
        <city>Munchen</city>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susanne Schmid</last_name>
      <phone>0049 89 5160 5 2414</phone>
      <email>Susanne_Schmid@med.uni-muenchen.de</email>
    </contact>
    <investigator>
      <last_name>Felix Beuschlein</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Max Planck Institute für Psychiatrie</name>
      <address>
        <city>Munchen</city>
        <zip>80804</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>E Stettberger</last_name>
      <phone>0049 89 3062 2593</phone>
      <email>stettberger@mpipsukl.mpg.de</email>
    </contact>
    <investigator>
      <last_name>Gunter Stalla</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medicover Oldenburg MVZ</name>
      <address>
        <city>Oldenburg</city>
        <zip>26122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Smadar Pahl</last_name>
      <phone>00 49 441 218 460</phone>
      <email>s.pahl@endokrin-ol.de</email>
    </contact>
    <investigator>
      <last_name>Michael Droste</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endokrinologiezentrum Ulm Praxis</name>
      <address>
        <city>Ulm</city>
        <zip>89073</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gwendolin Etzrodt-Walter</last_name>
      <email>info@endokrinologie-ulm.de</email>
    </contact>
    <investigator>
      <last_name>Gwendolin Etzrodt-Walter</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Würzburg</name>
      <address>
        <city>Wuerzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martina Zink</last_name>
      <phone>0049 93120139968</phone>
      <email>zink_m@klinik.uni-wuerzburg.de</email>
    </contact>
    <investigator>
      <last_name>Stephanie Hahner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Università degli Studi Federico II</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Rosario Pivonello</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Umberto I</name>
      <address>
        <city>Rome</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Andrea Isidori</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Universitario Agostino Gemelli</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Salvatore Corsello</last_name>
      <email>corsello.sm@mclink.it</email>
    </contact>
    <investigator>
      <last_name>Salvatore Corsello</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariska Groeneveld</last_name>
      <phone>0031503612987</phone>
      <email>m.a.groeneveld@umcg.nl</email>
    </contact>
    <investigator>
      <last_name>Andre van Beek</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erasmus MC</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sjaan Poldermans</last_name>
      <email>b.poldermans@erasmusmc.nl</email>
    </contact>
    <investigator>
      <last_name>Richard Feelders</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3584</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marjolijn Peltenburg</last_name>
      <email>mpeltenb@umcutrecht.nl</email>
    </contact>
    <investigator>
      <last_name>Pierre Zelissen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska Universitetssjukhuset</name>
      <address>
        <city>Gothenborg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina Cid Käll</last_name>
      <phone>004631471249</phone>
      <email>kristina.cid.kall@vgregion.se</email>
    </contact>
    <investigator>
      <last_name>Anna Nilsson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitetssjukhuset i Linköping</name>
      <address>
        <city>Linkoping</city>
        <zip>58185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sofia Sjoberg</last_name>
      <phone>0046703822234</phone>
      <email>sofia.k.sjoberg@regionostergotland.se</email>
    </contact>
    <investigator>
      <last_name>Bertil Ekman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B12 2TT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Niki Karavitaki</last_name>
      <phone>0044 1214 158 715</phone>
      <email>niki.karavitaki@uhb.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Nikki Karavitaki</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St James University Hospital</name>
      <address>
        <city>Leeds</city>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Lynch</last_name>
      <phone>0044113 20 64660</phone>
      <email>julie.lynch5@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Robert Murray</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barts and The London NHS Trust</name>
      <address>
        <city>London</city>
        <zip>EC1A 7BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Pheby</last_name>
      <phone>0044 20 7882 5660</phone>
      <email>j.m.pheby@qmul.ac.uk</email>
    </contact>
    <investigator>
      <last_name>William Drake</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Free Hospital</name>
      <address>
        <city>London</city>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Christie Hospital</name>
      <address>
        <city>Manchester</city>
        <zip>M20 4BX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoria Hutchinson</last_name>
      <phone>0044 (0)161 446 8132</phone>
      <email>Victoria.Hutchinson@christie.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Peter Trainer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Infirmary</name>
      <address>
        <city>Newcastle</city>
        <zip>NE1 4LP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Morris</last_name>
      <phone>0044 0191 282 0462</phone>
      <email>margaret.morris@nuth.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Simon Pearce</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Churchill Hospital</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 7LE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Violet Fazal-Sanderson</last_name>
      <phone>00441865 857266</phone>
      <email>violet.sanderson@ouh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Ashley Grossman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2012</study_first_submitted>
  <study_first_submitted_qc>August 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 9, 2012</study_first_posted>
  <last_update_submitted>January 26, 2017</last_update_submitted>
  <last_update_submitted_qc>January 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adrenal insufficiency</keyword>
  <keyword>DuoCort</keyword>
  <keyword>Congenital adrenal hyperplasia (CAH)</keyword>
  <keyword>Modified release</keyword>
  <keyword>Hydrocortisone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adrenal Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

